ARGX:NASDAQ
argenx SE - ADR
930,52 $
arrow_upward
+1,93%(+17,65) 1D
931,35 $
arrow_upward
+0,09% (+0,83)bedtimeAfter hours
Closed: 6 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
922,39 $
High
942,35 $
Low
909,94 $
Mkt. cap
58,45 млрд
Avg. vol.
255,97 м.
Volume
0,00
P/E ratio
35,35
52-wk high
1 072,75 $
52-wk low
661,85 $
EPS
26,32 $
Beta
0,45
Shares outstanding
62,56 млн
No. of employees
2 мың
Open
922,39 $
High
942,35 $
Low
909,94 $
Mkt. cap
58,45 млрд
Avg. vol.
255,97 м.
Volume
0,00
P/E ratio
35,35
52-wk high
1 072,75 $
52-wk low
661,85 $
EPS
26,32 $
Beta
0,45
Shares outstanding
62,56 млн
No. of employees
2 мың
News stories
From web sources and news partners
AD HOC NEWS
·
36 минут бұрын
Goldman Sachs raises target for Argenx stock to EUR 982.00
Investing.com UK
·
11 сағат бұрын
Halozyme expands argenx collaboration with two new targets By Investing.com
Stock Titan
·
11 сағат бұрын
A drug-delivery partnership expands from six exclusive targets to eight.
AD HOC NEWS
·
15 сағат бұрын
argenx stock: New VYVGART data span myasthenia gravis and CIDP
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR